How to Help Your Patients Find Temodar in Stock: A Provider's Guide

For oncology practices managing patients on temozolomide (Temodar), specialty pharmacy access issues are a recurring operational challenge. Patients with glioblastoma are often medically fragile, cognitively impaired, or relying on caregivers — calling pharmacies themselves is not always realistic. This guide provides practical workflows for your team to proactively manage temozolomide access for every patient on your roster.

Why Oncology Practices Must Own the Access Workflow

Unlike outpatient medications for chronic conditions, temozolomide access failures have immediate clinical consequences. A missed day of concurrent chemoradiation cannot simply be rescheduled. Patients managing a GBM diagnosis often have significant cognitive burden, and their caregivers are managing enormous stress. The burden of solving specialty pharmacy problems should not fall on patients.

Proactive, structured workflows in your practice protect patients and reduce last-minute crises for your team.

Step 1: Verify Insurance and Specialty Pharmacy at Initiation of Treatment

Before the first temozolomide prescription is sent, your office should:

Confirm the patient's insurance coverage and identify the in-network specialty pharmacy for chemotherapy

Submit prior authorization proactively — do not wait for the pharmacy to request it

Provide the specialty pharmacy with the patient's complete diagnosis, ICD-10 codes, and treatment plan

Establish a direct contact at the specialty pharmacy assigned to your practice for escalation purposes

Step 2: Build a 7–10 Day Lead Time Into Every Fill

For maintenance cycles, the Stupp protocol's 28-day cycle (5 days on, 23 days off) provides a natural refill window. Build a practice protocol:

Submit the prescription to the specialty pharmacy on day 18–20 of the current cycle (10 days before the next 5-day cycle starts)

Have your MA or patient navigator confirm receipt and availability with the pharmacy by day 23 of the cycle

If the pharmacy cannot confirm availability, immediately begin sourcing alternatives (backup specialty pharmacy, manufacturer, distribution contact)

Step 3: Maintain a Backup Pharmacy Contact List

Every oncology practice should maintain a list of specialty pharmacies with established relationships that stock temozolomide. This list should include:

Your primary specialty pharmacy partner and a direct account contact number

2–3 backup specialty pharmacies in your region (Accredo, BioPlus, CVS Specialty, Walgreens Specialty)

Your hospital or cancer center's own outpatient pharmacy (if available)

Merck's patient access program contact number for brand Temodar emergencies

38,717+ patients found their medications in stock

38K+

Find Temodar In Stock Today →

Step 4: Direct Patients to medfinder for Independent Search

For patients and caregivers who want to take an active role in locating their prescription, medfinder is a service that contacts pharmacies in the patient's area to check which ones can fill a specific prescription. The patient provides their medication, dosage, and ZIP code, and medfinder texts them results — no hold times, no repeated calls. This is especially helpful for caregivers managing a cognitively impaired GBM patient.

Consider including medfinder in your patient education materials or post-visit instructions for patients starting maintenance temozolomide.

Step 5: Educate Patients and Caregivers at Treatment Start

At the start of maintenance therapy, proactively educate patients and caregivers on:

How their specialty pharmacy works and how to contact it

The importance of requesting their refill at least 7–10 days before the next cycle

Who to call first if there's a problem filling the prescription (your clinic's triage line)

Resources like medfinder for locating alternative supply

Skip the calls, skip the stress.

Find Temodar In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Managing the Concurrent Phase: Extra Vigilance Required

The concurrent chemoradiation phase (temozolomide 75 mg/m2 daily x 42–49 days) has zero tolerance for supply gaps. During this phase, consider:

Verifying the initial supply before radiation begins — don't start chemoradiation if you haven't confirmed the full 6-7 week supply is secured

Building in a check at week 3 to confirm the remainder of the supply is in hand

For patients receiving IV temozolomide during this phase, having your inpatient or infusion center pharmacy confirm IV stock before each weekly session

See also: Temodar Shortage: What Providers and Prescribers Need to Know in 2026